Glucagon in Peptide Therapy: A Checklist Guide to Application Scope
Title: Glucagon in Peptide Therapy: A Checklist Guide to Application Scope Abstract: Glucagon, a 29-amino-acid peptide, is pivotal in peptide therapy for managing hypoglycemia and metabolic disorders. This checklist guide evaluates its application scope, comparing key brands (e.g., Novo Nordisk, Eli Lilly) on purity (>98%) and stability. Market trends show a 12.4% CAGR (2023–2030) driven by diabetes and obesity treatments. Technical advantages include rapid glucose mobilization; limitations involve short half-life ( 6 min). Product parameters (e.g., reconstitution time, storage at 2–8°C) and logistics (cold chain compliance) are critical. Factory GMP certification and FDA/EMA approvals ensure quality. Selection tips prioritize bioavailability and adverse effect profiles. Industry data highlight expanding uses in cardiac and gastrointestinal therapies.